Clinical Trial

Timing of Renal Replacement Therapy Initiation in Tumor Lysis Syndrome

Study acronym: TENDERS
Recruiting
View on ClinicalTrials.gov →
Summary
The TENDERS study aims to evaluate the impact of the timing of renal replacement therapy (RRT) initiation on outcomes in patients with tumor lysis syndrome (TLS) and associated acute kidney injury (AKI). The study will compare early versus delayed RRT initiation, examining the effect on renal function at 30 days post-treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-20.
Status change: Not Yet Recruiting → Recruiting 2026-01-08
Trial Details
NCT Number NCT06889974
Lead Sponsor University Hospital, Bordeaux
Conditions Renal Replacement Therapy for Acute Kidney Injury in ICU
Enrollment 800 participants
Start Date 2025-07-01
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-09